Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020

Emerg Infect Dis. 2024 Jan;30(1):136-140. doi: 10.3201/eid3001.230924.

Abstract

We assessed tuberculosis (TB) diagnostic delays among patients with TB and COVID-19 in California, USA. Among 58 persons, 43% experienced TB diagnostic delays, and a high proportion (83%) required hospitalization for TB. Even when viral respiratory pathogens circulate widely, timely TB diagnostic workup for at-risk persons remains critical for reducing TB-related illness.

Keywords: COVID-19; California; SARS-CoV-2; TB; United States; bacteria; coronavirus disease; coronaviruses; deaths; diagnostic delay; hospitalization; respiratory infections; severe acute respiratory syndrome coronavirus 2; treatment outcomes; tuberculosis; viruses.

MeSH terms

  • COVID-19 Testing
  • COVID-19* / diagnosis
  • California / epidemiology
  • Delayed Diagnosis
  • Humans
  • Treatment Outcome
  • Tuberculosis* / diagnosis
  • Tuberculosis* / drug therapy
  • Tuberculosis* / epidemiology